BRCA2 and breast carcinoma: Here, we apply a novel strategy using a case-only GWAS design51,52, in which SNP genotype frequencies in 7,257 BRCA1 and 5,097 BRCA2 mutation carrier BC cases are compared to those in 60,212 BC cases from the Breast Cancer Association Consortium (BCAC), unselected for mutation status.